News

Biontech Se Sponsored Adr ((BNTX)), Biontech SE (($CC:BNTX.CUR)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off ...
BioNTech (BNTX) recently experienced a 10% price increase in the last quarter, coinciding with the Health Canada's authorization of its variant-adapted COMIRNATY COVID-19 vaccine, a potential positive ...
Pfizer Canada ULC and BioNTech SE (Nasdaq: BNTX) "BioNTech" announced today that Health Canada has authorized the LP.8.1 ...
BioNTech ADR earns the No. 143 rank among its peers in the Medical-Biomed/Biotech industry group. Aurinia Pharmaceuticals ...
Pfizer's Canadian unit and BioNTech said they have received approval in Canada for their updated Comirnaty Covid-19 vaccine. The companies said Monday the updated vaccine targets the Omicron LP.8.1 ...
"This isn't a political statement," Dr. Lee Vogel said about vaccine safety. "This is just trying to provide some factual ...
The top executives running the health care industry’s blue-chip companies amassed generational wealth in 2024, even as many ...
A large retrospective study found that nearly a quarter of high-grade serous cancers occurred after missed chances to perform ...
Health Canada announced it has approved a new vaccine made by Pfizer Canada and BioNTech for the fall of 2025. According to ...
Researchers warn that halting federal contracts for mRNA vaccine research could weaken pandemic preparedness and slow medical advances.
Pfizer said Health Canada has approved its latest COVID-19 vaccine that targets a new Omicron variant. It will be made available in the fall.